S.975 - Project BioShield II Act of 2005109th Congress (2005-2006)
|Sponsor:||Sen. Lieberman, Joseph I. [D-CT] (Introduced 04/28/2005)|
|Latest Action:||07/21/2005 Committee on Health, Education, Labor, and Pensions. Held a roundtable discussion of the bill.|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Subject — Policy Area:
- View subjects
Summary: S.975 — 109th Congress (2005-2006)All Bill Information (Except Text)
Introduced in Senate (04/28/2005)
Project BioShield II Act of 2005 - Establishes: (1) the Terrorism and Infectious Disease Countermeasure Purchase Fund; (2) procurement pools for qualified countermeasures and security countermeasures; (3) the International Public Health Advisory Committee to develop strategies for establishing such pools; (4) the Office of Public Health Countermeasure Development within the Department of Health and Human Services (HHS) ; (5) the Office of Medical Readiness within the Office of the Secretary of the Department of Homeland Security (DHS) to assume functions of the National Disaster Medical System and the Metropolitan Medical Response System; (6) the National Emergency Medical Readiness and Response Board within DHS to oversee emergency medical response plans; (7) the National Center for Healthcare Technology Development to manage NIH intellectual property; (8) the Millennium Medicine Discovery Award; (9) the Office of the Deputy Commissioner for Biological, Chemical, Nuclear, Radiological and Infectious Disease Products; and (10) the Global Disease Detection Trust Fund.
Creates incentives for the development of countermeasures, including: (1) payments to manufacturers; (2) accelerated approval of countermeasures; (3) patent term restoration and extension; (4) exclusive marketing; (5) federal tax incentives; (6) reimbursements for production costs; (7) expedited processing of visa applications; (8) grants and contracts for the construction and management of biosafety level 3-4 facilities; and (9) grants and scholarships for personnel to conduct biodefense and infectious disease research.
Sets forth provisions regarding necessary research for countermeasure development, including research regarding: (1) diagnostics; (2) detection technology; (3) infectious diseases; (4) accurate animal models; (5) biologics; (6) vaccine adjuvants; (7) the production of cell culture; (8) vaccines; (9) zoonotic disease surveillance; and (10) agroterrorism research.
Bioshield Export Priority Act - Requires the Secretary of Commerce or the Secretary of Health and Human Services to expedite the processing of requests to export restricted items necessary to procure countermeasures.